- Home
- ATRA vs PNI Comparison
ATRA vs PNI Comparison
Compare ATRA & PNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRA
- PNI
- Stock Information
- Founded
- ATRA 2012
- PNI 2002
- Country
- ATRA United States
- PNI United States
- Employees
- ATRA N/A
- PNI N/A
- Industry
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- PNI Trusts Except Educational Religious and Charitable
- Sector
- ATRA Health Care
- PNI Finance
- Exchange
- ATRA Nasdaq
- PNI Nasdaq
- Market Cap
- ATRA 97.0M
- PNI 78.4M
- IPO Year
- ATRA 2014
- PNI N/A
- Fundamental
- Price
- ATRA $13.04
- PNI $6.95
- Analyst Decision
- ATRA Strong Buy
- PNI
- Analyst Count
- ATRA 3
- PNI 0
- Target Price
- ATRA $21.00
- PNI N/A
- AVG Volume (30 Days)
- ATRA 59.0K
- PNI 26.4K
- Earning Date
- ATRA 11-12-2025
- PNI 01-01-0001
- Dividend Yield
- ATRA N/A
- PNI 4.76%
- EPS Growth
- ATRA N/A
- PNI N/A
- EPS
- ATRA 1.97
- PNI N/A
- Revenue
- ATRA $151,930,000.00
- PNI N/A
- Revenue This Year
- ATRA N/A
- PNI N/A
- Revenue Next Year
- ATRA N/A
- PNI N/A
- P/E Ratio
- ATRA $6.70
- PNI N/A
- Revenue Growth
- ATRA 51.27
- PNI N/A
- 52 Week Low
- ATRA $5.01
- PNI $6.03
- 52 Week High
- ATRA $18.71
- PNI $7.89
- Technical
- Relative Strength Index (RSI)
- ATRA 47.86
- PNI 47.80
- Support Level
- ATRA $11.21
- PNI $6.93
- Resistance Level
- ATRA $14.28
- PNI $7.01
- Average True Range (ATR)
- ATRA 1.33
- PNI 0.05
- MACD
- ATRA 0.01
- PNI -0.01
- Stochastic Oscillator
- ATRA 52.74
- PNI 41.67
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
About PNI Pimco New York Municipal Income Fund II of Beneficial Interest
PIMCO New York Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State and New York City income tax. The fund portfolio of investments consists of investments in different sectors such as education, transportation, healthcare, and others.